Dow Up 2.00% Nasdaq Up 1.66%

More On UCB.BR

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

UCB S.A. (UCB.BR)

-Brussels
73.49 Up 2.04(2.86%) Feb 12, 11:35AM EST
Prev Close:73.49
Open:72.13
Bid:73.48 x 88800
Ask:73.59 x 123500
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:71.61 - 73.49
52wk Range:60.40 - 86.05
Volume:341,459
Avg Vol (3m):262,316
Market Cap:14.04B
P/E (ttm):41.66
EPS (ttm):1.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in EUR.

Headlines

» More Headlines for UCB.BR

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-11) :N/A
Quarterly EPS Est (Dec-11) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

UCB S.A., a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system in Belgium and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback